Subclinical inflammation in obese women with polycystic ovary syndrome

Subclinical inflammation in obese women with polycystic ovary syndrome

Objective: To study the relation between subclinical inflammation and metabolic disorders in obese women with polycystic ovary syndrome (PCOS). Design: A cross sectional case controlled study. Main outcome measure: Anti-inflammatory and pro-inflammatory biomarkers. Materials and methods: Sixty-three...

Full description

Bibliographic Details
Main Authors:	Dina Gamal Eldeen Y. Elkholi, Sahar F. Hammoudah
Format:	Article
Language:	English
Published:	SpringerOpen 2012-09-01
Series:	Middle East Fertility Society Journal
Subjects:	Polycystic ovary syndrome Insulin resistance Android and gynoid obesity IL-10 Adiponectin Prothrombin activator inhibitor-1 Interleukin-6 hsC-reactive protein
Online Access:	http://www.sciencedirect.com/science/article/pii/S1110569012000088

Similar Items

The effects of adipocytokines on the endocrino-metabolic features and obstetric outcome in pregnant obese women with polycystic ovary syndrome
by: Dina Gamal Eldeen Y. Elkholi, et al.
Published: (2014-12-01)

The probiotic supplementation reduced inflammation in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
by: Nila Ghanei, et al.
Published: (2018-03-01)

Serum Adiponectin Level and Clinical, Metabolic, and Hormonal Markers in Patients with Polycystic Ovary Syndrome
by: Yunus Yildiz, et al.
Published: (2014-01-01)

Leptin, Ghrelin, Adiponectin, Homocysteine and Insulin Resistance Related to Polycystic Ovary Syndrome
by: Saghar Salehpour, et al.
Published: (2008-11-01)

Determination of Serum Adiponectin Levels in Normal Weight Women with Polycystic Ovary Syndrome
by: Rana A. Hamdi, et al.
Published: (2015-07-01)

Hormonal and adiposity state of women with polycystic ovary syndrome: implication of adiponectin and leptin
by: Aleksandra Atanasova Boshku, et al.
Published: (2016-12-01)

Oral Quercetin Supplementation Enhances Adiponectin Receptor Transcript Expression in Polycystic Ovary Syndrome Patients: A Randomized Placebo-Controlled Double-Blind Clinical Trial
by: Neda Rezvan, et al.
Published: (2017-11-01)

Relationship between Serum Levels of Anti-Mullerian Hormone, Adiponectin and Oxidative Stress Markers in Patients with Polycystic Ovary Syndrome
by: Mozhgan Kohzadi, et al.
Published: (2020-04-01)

Assessing the variability and predictability of adipokines (adiponectin, leptin, resistin and their ratios) in non-obese and obese women with anovulatory polycystic ovary syndrome
by: Christian Obirikorang, et al.
Published: (2019-08-01)

The incidence and features of subclinical Cushing’s syndrome in women with polycystic ovaries
by: Yu.M. Urmanova, et al.
Published: (2017-04-01)

Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)
by: Farnaz Kamali Haghighi Shirazi, et al.
Published: (2021-03-01)

Adipokines and a risk for metabolic disturbances in different types of female obesity
by: V G Selyatitskaya, et al.
Published: (2015-10-01)

Levels of cytokines profile in polycystic ovary syndrome
by: Shafaq H. Hussein Al-Musawy, et al.
Published: (2018-01-01)

Investigating the relationship of serum levels of afamin and interleukin-10 with insulin resistance in infertile women with polycystic ovary syndrome
by: Tuğba Gürbüz, et al.
Published: (2021-03-01)

Association between Interleukin-32 and Interleukin-17A Single Nucleotide Polymorphisms and Serum Levels with Polycystic Ovary Syndrome
by: Fateme Hesampour, et al.
Published: (2019-02-01)

Hypoadiponectinemia: A useful marker of dyslipidemia in women with polycystic ovary syndrome
by: Chih-Yuan Chang, et al.
Published: (2012-12-01)

Reduced angiopoietin-2 as a predictive biomarker for clomiphene citrate resistance in polycystic ovary syndrome
by: Luxmipratha Rajendiran, et al.
Published: (2021-01-01)

The Effects of L-dopa, SCH23390 Hydrochloride and Sulpiride on Adiponectin and Luteinizing Hormone Levels in an Animal Model of Polycystic Ovary Syndrome
by: Khadijeh Haghighat Gollo, et al.
Published: (2020-05-01)

Polycystic Ovary Syndrome in Adolescence
by: Rebecca Deans
Published: (2019-10-01)

The relationship between intestinal microbiota and polycystic ovary syndrome
by: Katarzyna Korabiusz, et al.
Published: (2019-05-01)

Prevalence of hypovitaminosis D, and its association with hypoadiponectinemia and hyperfollistatinemia, in Saudi women with naïve polycystic ovary syndrome
by: Osama Adnan Kensara
Published: (2018-06-01)

Estrogen Receptors in Polycystic Ovary Syndrome
by: Xue-Ling Xu, et al.
Published: (2021-02-01)

Serum Anti-Müllerian hormone in polycystic ovary syndrome and its relationship with insulin resistance, lipid profile and adiponectin
by: Thien Jun Jun, et al.
Published: (2020-01-01)

Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
by: Mohd Ashraf Ganie, et al.
Published: (2019-11-01)

Chronic inflammation in polycystic ovary syndrome: A case–control study using multiple markers
by: Soumik Goswami, et al.
Published: (2021-04-01)

Subclinical Hypothyroidism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
by: Xiaohong Ding, et al.
Published: (2018-11-01)

Valproate, Menstrual Disorder and Polycystic Ovaries
by: J Gordon Millichap
Published: (2000-08-01)

Ovulation induction in polycystic ovary syndrome
by: Ali İrfan Güzel, et al.
Published: (2014-12-01)

The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
by: Ran Y, et al.
Published: (2021-03-01)

LncRNA GAS5 is upregulated in polycystic ovary syndrome and regulates cell apoptosis and the expression of IL-6
by: Chunxia Wang, et al.
Published: (2020-12-01)

Inter-observer variability in the assessment of ultrasound features of polycystic ovaries
by: Rami Kilani, et al.
Published: (2017-09-01)

Lipid Parameters in Patients with Polycystic Ovary Syndrome
by: Cristian Ioan IUHAS, et al.
Published: (2012-11-01)

SURGICAL TREATMENT OF POLYCYSTIC OVARIES IN INFERTILE PATIENTS
by: Martina Ribič Pucelj, et al.
Published: (2003-12-01)

Polycystic Ovary Induction in Mouse by Testosterone Enanthate
by: Zahra Kalhori, et al.
Published: (2014-03-01)

The conservative treatment in adolescents with the Polycystic ovary syndrome
by: Adrian NEACȘU, et al.
Published: (2016-12-01)

The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial
by: Fatemeh Haidari, et al.
Published: (2020-01-01)

Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome
by: Anil Satyaraddi, et al.
Published: (2019-01-01)

The prevalence of polycystic ovaries in infertility by laparoscopy ‎
by: Tahereh Ziaie, et al.
Published: (2013-09-01)

Evaluation of Thyroid Function Status in Polycystic Ovary Syndrome
by: Dr. Syeda Sobia Harmain1 , Dr. Mohd Inayatulla Khan2
Published: (2020-04-01)

Homocysteine levels in Indian women with Polycystic Ovary Syndrome
by: Mehmet Agilli, et al.
Published: (2014-10-01)